First Meril MyVal Heart Valve Implantations in New Zealand

Obex in conjunction with supplier partner Meril Life Sciences are extremely excited about their latest innovation.  Auckland City Hospital have just completed the first two implantations of the Meril Myval THV (Transcatheter Heart Valve) in New Zealand and Australasia. The Meril Life Sciences Myval THV has been implanted in over 4500 patients globally and has some unique features including an improved, faster delivery and deployment system, intermediate sizing (allowing for more accurate fit for patients) and the largest valve sizes available in the market.

Below is Dr Mark Webster with the Auckland City Hospital Interventional Cardiology team post implantation.